Karleigh A. Hamblin

Salisbury, ENG SP40JQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Inhaled Ciprofloxacin as an Alternative Treatment for Infection with Coxiella burnetii.

Inhaled Ciprofloxacin as an Alternative Treatment for Infection with Coxiella burnetii.

Journal: Antibiotics (Basel, Switzerland)

Published: January 13, 2026

Development and operation of the defence COVID-19 lab as a SARS-CoV-2 diagnostic screening capability for UK military personnel.

Development and operation of the defence COVID-19 lab as a SARS-CoV-2 diagnostic screening capability for UK military personnel.

Journal: BMJ military health

Published: May 04, 2022

Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.

Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.

Journal: Frontiers in cellular and infection microbiology

Published: November 11, 2021

Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.

Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms.

Journal: Frontiers in cellular and infection microbiology

Published: June 10, 2021

ATP-specificity of succinyl-CoA synthetase from Blastocystis hominis.

ATP-specificity of succinyl-CoA synthetase from Blastocystis hominis.

Journal: Acta crystallographica. Section D, Structural biology

Published: March 04, 2019

The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4.

The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4.

Journal: Frontiers in microbiology

Published: February 14, 2019

Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.

Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.

Journal: International journal of antimicrobial agents

Published: January 08, 2019

The Human Gut Colonizer Blastocystis Respires Using Complex II and Alternative Oxidase to Buffer Transient Oxygen Fluctuations in the Gut.

The Human Gut Colonizer Blastocystis Respires Using Complex II and Alternative Oxidase to Buffer Transient Oxygen Fluctuations in the Gut.

Journal: Frontiers in cellular and infection microbiology

Published: June 15, 2018

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.

Journal: Antimicrobial agents and chemotherapy

Published: January 20, 2017

Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague.

Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague.

Journal: Frontiers in microbiology

Published: October 06, 2016

Engineering Nucleotide Specificity of Succinyl-CoA Synthetase in Blastocystis: The Emerging Role of Gatekeeper Residues.

Engineering Nucleotide Specificity of Succinyl-CoA Synthetase in Blastocystis: The Emerging Role of Gatekeeper Residues.

Journal: Biochemistry

Published: August 02, 2016

Efficacy of liposome-encapsulated ciprofloxacin in a murine model of Q fever.

Efficacy of liposome-encapsulated ciprofloxacin in a murine model of Q fever.

Journal: Antimicrobial agents and chemotherapy

Published: July 09, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026